- Reaction score
- 103
IMO the bigger takeaway here is they're moving at a really fast pace for a biotech startup, with their endo phase II trial already recruiting before EOY 2021
a promising signal they'll also be able to move faster towards testing it for Androgenetic Alopecia (regardless of the specifics of their business strategy)
the celebration and focus on some bureaucratic paperwork is a just reflection of how starved the hair loss community always is for information outside of press releases
nuance is dead
a promising signal they'll also be able to move faster towards testing it for Androgenetic Alopecia (regardless of the specifics of their business strategy)
the celebration and focus on some bureaucratic paperwork is a just reflection of how starved the hair loss community always is for information outside of press releases
nuance is dead